PSMA is a transmembrane receptor that is highly expressed on prostate cancer cells and tumor-associated vascular endothelium, particularly in advanced metastatic castration-resistant prostate cancer (mCRPC), and its expression in other normal tissues is minimal. Here, FOLH1 is linked to neoplasm.